Geode Capital Management, LLC In8 Bio, Inc. Transaction History
Geode Capital Management, LLC
- $1.21 Trillion
- Q3 2024
A detailed history of Geode Capital Management, LLC transactions in In8 Bio, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 329,274 shares of INAB stock, worth $111,953. This represents 0.0% of its overall portfolio holdings.
Number of Shares
329,274
Previous 317,370
3.75%
Holding current value
$111,953
Previous $269,000
67.29%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding INAB
# of Institutions
28Shares Held
8.01MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD2.13MShares$723,5190.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$484,1240.0% of portfolio
-
Ensign Peak Advisors, Inc Salt Lake City, UT1.12MShares$380,2100.0% of portfolio
-
Sigma Planning Corp Ann Arbor, MI851KShares$289,4350.01% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL641KShares$217,9420.0% of portfolio
About IN8BIO, INC.
- Ticker INAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,502,200
- Market Cap $8.33M
- Description
- IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...